Clinical Trial Update: RE and Probiotics in MAFLD/NAFLD [NA]

View source ↗

Summary

Clinical trial update from Nicolaus Copernicus University evaluating RE and probiotics for metabolic dysfunction-associated fatty liver disease (MAFLD/NAFLD) in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease
• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Probiotic therapy
• RE

Snippet

Sponsor: Nicolaus Copernicus University | Conditions: NASH, NAFLD | NA | Status: NOT_YET_RECRUITING